Top Markets
Coin of the day
CompuGroup Medical SE & Co. KGaA CompuGroup Medical SE & Co. KGaA

CompuGroup Medical SE & Co. KGaA

COP
Clasificación en acciones #7996
CompuGroup Medical SE & Co. KGaA (CGM) is a global developer and vendor of... CompuGroup Medical SE & Co. KGaA (CGM) is a global developer and vendor of sophisticated information technology and software solutions tailored for the healthcare industry. The company organizes its diverse offerings into four primary operational segments: Ambulatory Information Systems (AIS): This segment furnishes physicians, medical centers, and professional networks with essential practice management software and electronic medical records. It also provides complementary internet and intranet-based tools to support outpatient care. Pharmacy Information Systems (PCS): Focusing on the pharmaceutical sector, PCS delivers administrative and billing software applications designed for pharmacies. These solutions offer critical information and decision-making support for managing the intricate medication supply chain. Hospital Information Systems (HIS): Catering to the inpatient environment, this segment provides comprehensive clinical and administrative solutions. Its clientele includes acute care hospitals, rehabilitation facilities, social service organizations, multi-site hospital networks, regional care providers, and medical laboratories. Consumer & Health Management Information Systems (CHS): This broad segment encompasses services such as IT security, data-driven product suites, interfaces for information exchange, clinical decision support tools, and extensive medication and treatment databases for healthcare service providers. Additionally, it develops digital healthcare platforms, consumer portals, and mobile applications, along with security measures for providers. Its customer base is expansive, covering pharmaceutical companies, health insurance providers, other healthcare IT firms, and direct consumers. Founded in 1987 and headquartered in Koblenz, Germany, the company officially adopted its current designation, CompuGroup Medical SE & Co. KGaA, in June 2020, having previously operated as CompuGroup Medical SE.
Precio por acción
$26.88
Última sincronización: 2025-06-24
Capitalización bursátil
$1.39B
Cambio (1 día)
3.42%
Cambio (1 año)
0.00%
País
DE
Comercio CompuGroup Medical SE & Co. KGaA (COP)

Categoría

Ratio P/E de CompuGroup Medical SE & Co. KGaA (COP)
Ratio P/E al August 2026 TTM: 33.82
Según los últimos informes financieros y el precio de las acciones de CompuGroup Medical SE & Co. KGaA, el P/E actual (TTM) de la empresa es 33.82. Al final de 2023, la empresa tenía un P/E de 43.23.
Historial del ratio P/E de CompuGroup Medical SE & Co. KGaA desde 2004 hasta 2026
Relación P/E al final de cada año
Año Ratio P/E Cambiar
2026 (TTM) 33.82 3.94%
2024 32.54 -24.74%
2023 43.23 68.86%
2022 25.60 -52.58%
2021 53.98 -6.45%
2020 57.70 23.06%
2019 46.89 124.20%
2018 20.91 -76.82%
2017 90.22 107.43%
2016 43.49 -0.38%
2015 43.66 14.73%
2014 38.05 -4.25%
2013 39.74 66.79%
2012 23.83 -47.20%
2011 45.13 36.25%
2010 33.12 3.20%
2009 32.09 -74.10%
2008 123.91 338.44%
2007 28.26 26.47%
2006 22.35 162.71%
2005 8.51 -35.79%
2004 13.25 0.00%
Relación P/E para empresas similares o competidores
Empresa P/E Ratio Diferencia del P/E Ratio País
21.18 -37.39%
US
79.49 135.04%
AU
43.15 27.60%
US
-36.43 -207.73%
US
- -
US
¿Cómo leer un P/E ratio?

El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.

Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.

Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.